|
Description
Edwards Lifesciences Corporation (Irvine, CA) has completed its acquisition of Percutaneous Valve Technologies, Inc. (Fort Lee, NJ). Edwards had announced its intent to acquire Percutaneous in December of 2003.
Under terms of the agreement Edwards is paying the shareholders of Percutaneous $125 million cash, plus up to an additional $30 million in payments upon the achievement of key milestones. Consistent with earlier disclosures, the company expects to take an initial in-process research and development charge related to this transaction in... |
More articles from BIOTECH Patent News
Protein Design Labs receives license fees for humanized antibodies.(Pr..., February 01, 2004
Alnylam licenses gene silencing technology from Cold Spring Harbor.(Al..., February 01, 2004
Neurogen, Merck agreement for pain drugs cleared.(Neurogen Corporation..., February 01, 2004
Enzon and INEX form partnership for oncology therapy.(Enzon Pharmaceut..., February 01, 2004
Alnylam grants RNAx license to key patent in RNA interference.(German ..., February 01, 2004
Looking for additional articles?
Click here
to search our database of over 3 million articles.
|
%20%20&position=1)